StoryTel AB (0GBU)
London Exchange · UK · prices in SEK · close of 19 Oct 2026
Key indicators
| Last close | SEK 112.70 |
|---|---|
| 52-week range | 66.63 – 120.10 |
| Return, 1 month / 3 months | −1.5% / +25.1% |
| Return, 1 year / 3 years | +43.3% / +112.7% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 45 |
| Volatility (1 year) | 39.9% |
| Worst drawdown (1 year) | -23.7% |
| Average daily value traded | 1.21M SEK |
| Dividend yield | 1.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Storytel is a subscription service for audiobooks and electronic books, based in Stockholm, Sweden. Customers pay a recurring fee that gives them access to a catalogue of spoken and written titles through a mobile application, and the company also produces and publishes its own audio content. It serves readers and listeners in its home market and in a number of other countries, offering books in local languages alongside translated works.
The shares are listed on the London Exchange in UK under the code 0GBU, and the price on this page is in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
StoryTel AB (0GBU) trades on the London Exchange in UK. It last closed at SEK 112.70 on 19 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 837 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 43.3% and over the last three months it rose 25.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 86 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 18.5% | ||
| From 52-week high | -5.4% | ||
| Momentum | 83 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 25.1% | ||
| 6-month return | 11.8% | ||
| 12-month return, skipping the last month | 45.5% | ||
| Stability (higher is calmer) | 52 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 39.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.7% | ||
| Liquidity | 55 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.21M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 27 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.3% | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −3.0% |
|---|---|
| 1 month | −1.5% |
| 3 months | +25.1% |
| 6 months | +11.8% |
| 1 year | +43.3% |
| 3 years | +112.7% |
| 5 years | – |
Signals
| 50-day / 200-day average | 112.71 / 95.13 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.51 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 May 2026 | SEK 1.5000 |
| 7 May 2025 | SEK 1.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.